ARTIVION INC (AORT) Stock Fundamental Analysis

NYSE:AORT • US2289031005

36.6 USD
-4.05 (-9.96%)
At close: Feb 13, 2026
36.6 USD
0 (0%)
After Hours: 2/13/2026, 8:04:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

5

Overall AORT gets a fundamental rating of 5 out of 10. We evaluated AORT against 186 industry peers in the Health Care Equipment & Supplies industry. AORT has only an average score on both its financial health and profitability. AORT has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • In the past year AORT was profitable.
  • AORT had a positive operating cash flow in the past year.
  • AORT had negative earnings in each of the past 5 years.
  • In multiple years AORT reported negative operating cash flow during the last 5 years.
AORT Yearly Net Income VS EBIT VS OCF VS FCFAORT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M

1.2 Ratios

  • AORT's Return On Assets of -1.06% is fine compared to the rest of the industry. AORT outperforms 72.04% of its industry peers.
  • Looking at the Return On Equity, with a value of -2.08%, AORT is in the better half of the industry, outperforming 72.04% of the companies in the same industry.
  • AORT has a better Return On Invested Capital (2.28%) than 68.82% of its industry peers.
Industry RankSector Rank
ROA -1.06%
ROE -2.08%
ROIC 2.28%
ROA(3y)-2.68%
ROA(5y)-2.4%
ROE(3y)-7.46%
ROE(5y)-6.47%
ROIC(3y)N/A
ROIC(5y)N/A
AORT Yearly ROA, ROE, ROICAORT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 -10

1.3 Margins

  • With a decent Operating Margin value of 5.26%, AORT is doing good in the industry, outperforming 69.89% of the companies in the same industry.
  • AORT's Operating Margin has improved in the last couple of years.
  • With a decent Gross Margin value of 64.50%, AORT is doing good in the industry, outperforming 68.28% of the companies in the same industry.
  • In the last couple of years the Gross Margin of AORT has remained more or less at the same level.
Industry RankSector Rank
OM 5.26%
PM (TTM) N/A
GM 64.5%
OM growth 3Y34.21%
OM growth 5Y6.88%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.05%
GM growth 5Y-0.68%
AORT Yearly Profit, Operating, Gross MarginsAORT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so AORT is destroying value.
  • There is no outstanding debt for AORT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
AORT Yearly Shares OutstandingAORT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
AORT Yearly Total Debt VS Total AssetsAORT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

  • An Altman-Z score of 3.60 indicates that AORT is not in any danger for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 3.60, AORT is in the better half of the industry, outperforming 73.12% of the companies in the same industry.
  • AORT has a debt to FCF ratio of 12.48. This is a negative value and a sign of low solvency as AORT would need 12.48 years to pay back of all of its debts.
  • The Debt to FCF ratio of AORT (12.48) is better than 71.51% of its industry peers.
  • AORT has a Debt/Equity ratio of 0.50. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.50, AORT is in line with its industry, outperforming 41.94% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.5
Debt/FCF 12.48
Altman-Z 3.6
ROIC/WACC0.23
WACC9.89%
AORT Yearly LT Debt VS Equity VS FCFAORT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

  • A Current Ratio of 3.93 indicates that AORT has no problem at all paying its short term obligations.
  • AORT has a Current ratio of 3.93. This is in the better half of the industry: AORT outperforms 67.74% of its industry peers.
  • AORT has a Quick Ratio of 2.88. This indicates that AORT is financially healthy and has no problem in meeting its short term obligations.
  • AORT has a better Quick ratio (2.88) than 65.59% of its industry peers.
Industry RankSector Rank
Current Ratio 3.93
Quick Ratio 2.88
AORT Yearly Current Assets VS Current LiabilitesAORT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 169.77% over the past year.
  • Measured over the past 5 years, AORT shows a small growth in Earnings Per Share. The EPS has been growing by 5.46% on average per year.
EPS 1Y (TTM)169.77%
EPS 3YN/A
EPS 5Y5.46%
EPS Q2Q%143.59%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%19.2%

3.2 Future

  • AORT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 53.79% yearly.
  • The Revenue is expected to grow by 12.02% on average over the next years. This is quite good.
EPS Next Y50.62%
EPS Next 2Y45.66%
EPS Next 3Y74.4%
EPS Next 5Y53.79%
Revenue Next Year10.96%
Revenue Next 2Y11.28%
Revenue Next 3Y11.44%
Revenue Next 5Y12.02%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
AORT Yearly Revenue VS EstimatesAORT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M
AORT Yearly EPS VS EstimatesAORT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 2

More info and screens

Find the best growth stocksShow best growing peers

4

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 122.00, AORT can be considered very expensive at the moment.
  • 65.59% of the companies in the same industry are more expensive than AORT, based on the Price/Earnings ratio.
  • The average S&P500 Price/Earnings ratio is at 27.97. AORT is valued rather expensively when compared to this.
  • AORT is valuated quite expensively with a Price/Forward Earnings ratio of 81.00.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of AORT indicates a somewhat cheap valuation: AORT is cheaper than 66.13% of the companies listed in the same industry.
  • AORT's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.96.
Industry RankSector Rank
PE 122
Fwd PE 81
AORT Price Earnings VS Forward Price EarningsAORT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, AORT is valued a bit cheaper than 66.67% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, AORT is valued a bit cheaper than the industry average as 68.82% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 99.07
EV/EBITDA 45.78
AORT Per share dataAORT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • AORT's earnings are expected to grow with 74.40% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.41
PEG (5Y)22.35
EPS Next 2Y45.66%
EPS Next 3Y74.4%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for AORT!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ARTIVION INC

NYSE:AORT (2/13/2026, 8:04:00 PM)

After market: 36.6 0 (0%)

36.6

-4.05 (-9.96%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-12
Earnings (Next)05-04
Inst Owners87.09%
Inst Owner ChangeN/A
Ins Owners4.09%
Ins Owner Change-5.24%
Market Cap1.73B
Revenue(TTM)N/A
Net Income(TTM)-9.12M
Analysts83.08
Price Target52.75 (44.13%)
Short Float %3.69%
Short Ratio4.79
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)1085.72%
Min EPS beat(2)243.19%
Max EPS beat(2)1928.24%
EPS beat(4)3
Avg EPS beat(4)431.47%
Min EPS beat(4)-537.25%
Max EPS beat(4)1928.24%
EPS beat(8)6
Avg EPS beat(8)226.74%
EPS beat(12)8
Avg EPS beat(12)127.86%
EPS beat(16)11
Avg EPS beat(16)63.37%
Revenue beat(2)1
Avg Revenue beat(2)0.73%
Min Revenue beat(2)-1.12%
Max Revenue beat(2)2.59%
Revenue beat(4)2
Avg Revenue beat(4)-0.44%
Min Revenue beat(4)-5.37%
Max Revenue beat(4)2.59%
Revenue beat(8)4
Avg Revenue beat(8)0.31%
Revenue beat(12)7
Avg Revenue beat(12)0.63%
Revenue beat(16)10
Avg Revenue beat(16)0.6%
PT rev (1m)0%
PT rev (3m)14.27%
EPS NQ rev (1m)-6.66%
EPS NQ rev (3m)14.29%
EPS NY rev (1m)4.43%
EPS NY rev (3m)78.32%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.93%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.92%
Valuation
Industry RankSector Rank
PE 122
Fwd PE 81
P/S 4.1
P/FCF 99.07
P/OCF 56.92
P/B 3.95
P/tB 62.24
EV/EBITDA 45.78
EPS(TTM)0.3
EY0.82%
EPS(NY)0.45
Fwd EY1.23%
FCF(TTM)0.37
FCFY1.01%
OCF(TTM)0.64
OCFY1.76%
SpS8.92
BVpS9.26
TBVpS0.59
PEG (NY)2.41
PEG (5Y)22.35
Graham Number7.91
Profitability
Industry RankSector Rank
ROA -1.06%
ROE -2.08%
ROCE 2.88%
ROIC 2.28%
ROICexc 2.52%
ROICexgc 6.11%
OM 5.26%
PM (TTM) N/A
GM 64.5%
FCFM 4.14%
ROA(3y)-2.68%
ROA(5y)-2.4%
ROE(3y)-7.46%
ROE(5y)-6.47%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y40.9%
ROICexgc growth 5Y5.66%
ROICexc growth 3Y48.24%
ROICexc growth 5Y9.09%
OM growth 3Y34.21%
OM growth 5Y6.88%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.05%
GM growth 5Y-0.68%
F-Score5
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 0.5
Debt/FCF 12.48
Debt/EBITDA 4.81
Cap/Depr 56.35%
Cap/Sales 3.07%
Interest Coverage 250
Cash Conversion 67.34%
Profit Quality N/A
Current Ratio 3.93
Quick Ratio 2.88
Altman-Z 3.6
F-Score5
WACC9.89%
ROIC/WACC0.23
Cap/Depr(3y)42.06%
Cap/Depr(5y)43.23%
Cap/Sales(3y)2.8%
Cap/Sales(5y)3.13%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)169.77%
EPS 3YN/A
EPS 5Y5.46%
EPS Q2Q%143.59%
EPS Next Y50.62%
EPS Next 2Y45.66%
EPS Next 3Y74.4%
EPS Next 5Y53.79%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%19.2%
Revenue Next Year10.96%
Revenue Next 2Y11.28%
Revenue Next 3Y11.44%
Revenue Next 5Y12.02%
EBIT growth 1Y-25.58%
EBIT growth 3Y46.49%
EBIT growth 5Y14.43%
EBIT Next Year116.09%
EBIT Next 3Y44.04%
EBIT Next 5Y34.17%
FCF growth 1Y4464.09%
FCF growth 3YN/A
FCF growth 5Y7.33%
OCF growth 1Y292.01%
OCF growth 3YN/A
OCF growth 5Y7.04%

ARTIVION INC / AORT FAQ

Can you provide the ChartMill fundamental rating for ARTIVION INC?

ChartMill assigns a fundamental rating of 5 / 10 to AORT.


What is the valuation status of ARTIVION INC (AORT) stock?

ChartMill assigns a valuation rating of 4 / 10 to ARTIVION INC (AORT). This can be considered as Fairly Valued.


Can you provide the profitability details for ARTIVION INC?

ARTIVION INC (AORT) has a profitability rating of 4 / 10.


What are the PE and PB ratios of ARTIVION INC (AORT) stock?

The Price/Earnings (PE) ratio for ARTIVION INC (AORT) is 122 and the Price/Book (PB) ratio is 3.95.